Learn More
We have tested the predictive value of apparent diffusion coefficient (ADC) histogram analysis in stratifying progression-free survival (PFS) and overall survival (OS) in bevacizumab-treated patients(More)
The editors and staff of Neuro-Oncology are thrilled to announce that the journal's Impact Factor has increased yet again, from 5.723 to an impressive 6.180 for 2012. The journal is now ranked 9th of(More)